IL6 and lung cancer: The interleukin-6 (IL-6)/Janus kinase (JAK)/signal transducer and activator of transcription 3 (STAT3) signaling pathway is overactive in multiple cancer types, including lung cancer, and is important in cancer pathogenesis [11].